Researchers mapped myelin-making cells in mice, showing some brain regions recover better after myelin damage.

Bladder issues are a daily reality for many with MS, writes columnist Desiree Lama, who encourages more open discussion about the topic.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and ...

A new community-led network called PRADA enables underrepresented patients living with MS to help set research priorities.

Real-world data show Ocrevus reduced relapse rates and maintained disability stability in relapsing MS over four years.

UCSF is teaming up with Nektar to study NKTR-0165, an experimental antibody that activates the TNFR2 receptor, as a treatment ...

Continued treatment with Briumvi provided sustained clinical benefits to patients with relapsing MS, particularly when ...

Columnist Ben Hofmeister may rely on others for daily living, but trusting people isn't the same as giving up, he says.

Breastfeeding for longer in infancy may be associated with lower disease severity and a later onset of MS in adulthood, a ...